Season 3 kicks off with Professor Richard Sullivan (King’s College London) on why cancer outcomes depend less on shiny tech and more on end-to-end systems that actually work. We dig into affordability, widening inequalities, and why “reality-stratified” care beats one-size-fits-all blueprints.

Richard unpacks adaptive HTA and health-benefit packages, the limits of screening without treatment pathways, the UK’s own pressure points, and what equitable cancer control looks like in rural, fragile, and conflict settings.

We also talk financing—domestic resource mobilisation, the role of multilateral development banks, and why political commitment matters more than headlines.

Host: Paul Adepoju

Guest: Prof Richard Sullivan, Director, Institute of Cancer Policy, King’s College London

Companion read: Paul’s feature from this interview in The Lancet Oncology: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00591-1/abstract

If you enjoy the show, follow, rate, and share “Paul Talks Science.” New episodes every Monday.